ARCHIVES

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Lung Cancer Incidence Decreases Significantly In White Males For First Time In At Least 30 Years

December 6, 1985

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989